BrocColinate 60 mg Extra Strength 120c by NuMedica
NuMedica BrocColinate 60 mg Extra Strength 120c is a detox supplement designed to support overall health.* Its main active substance is Sulforaphane Glucosinolate, known for its powerful detoxifying properties.*
Who May Use BrocColinate 60 mg Extra Strength?
BrocColinate 60 mg Extra Strength by NuMedica may be for those who:
- are looking to support their colon and prostate health*
- need assistance with total body detoxification*
- want to bolster their immune system response*
- are seeking cardiovascular health support*
- desire optimal joint health support*
What May BrocColinate 60 mg Extra Strength by NuMedica Support?
NuMedica BrocColinate 60 mg Extra Strength may:
- enhance detoxification and protection against chemical toxins and free radicals*
- activate of natural detoxification enzymes*
- support immune and cardiovascular health*
- improved joint health*
Supplements support your health but do not replace a balanced diet. Always consult your healthcare provider if you have any doubts about a new supplement. You can also book a FREE product consultation with a medical advisor to discuss BrocColinate 60 mg Extra Strength 120c or other supplements sold at Covenant Health Products.
Recommendation:
NuMedica suggests taking one capsule per day or as directed by your healthcare practitioner.
Serving Size: 1 Capsule
Servings Per Container: 60
Amount Per Serving:
Broccoli (Brassica oleracea L. italica) (seed) extract 600 mg
Providing:
Sulforaphane Glucosinolate 60 mg
Other Ingredients: Hydroxypropyl methylcellulose (vegetable capsule).
Does Not Contain: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy.
Sulforaphane Glucosinolate is produced under U.S. patents: 5,725,895; 5,968,567; 6,177,122; 6,242,018; 7,303,770 and patents pending.
References:
- Bai, Y., Wang, X., Zhao, S., Ma, C., Cui, J., & Zheng, Y. (2015). Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation. Oxidative medicine and cellular longevity, 2015, 407580. https://doi.org/10.1155/2015/407580
- Zakkar, M., Van der Heiden, K., Luong, leA., Chaudhury, H., Cuhlmann, S., Hamdulay, S. S., Krams, R., Edirisinghe, I., Rahman, I., Carlsen, H., Haskard, D. O., Mason, J. C., & Evans, P. C. (2009). Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arteriosclerosis, thrombosis, and vascular biology, 29(11), 1851–1857. https://doi.org/10.1161/ATVBAHA.109.193375